Which companies developing cancer drugs are attractive takeover targets? Seeking Alpha analysts offer their picks. Read more here.

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

Leerink Partners previews the drugs likely to be subject to the Inflation Reduction Act’s next price negotiations as the ...

Introduction Oncology drugs are medications used to prevent or treat cancer. These include chemotherapy, targeted therapy, immunotherapy, and h ...

Stocks of cancer treatment developers will be moving into the spotlight later this week when the annual meeting of the ...

START and OneOncology launch 3 new early-phase trial sites, expanding access to new cancer research in community oncology ...

The medium-sized biopharma is showing off new results from dordaviprone and Zepzelca, both of which were acquired through ...

New breast cancer drug vepdegestrant shows promising results in increasing survival rates for patients with ESR1 mutations.

Victoria’s VoxCell BioInnovation and game developer Kano were among the hundreds of firms at Web Summit Vancouver this week ...

After Merck paid a hefty sum to co-develop and co-commercialize HER3-DXd, the drug has suffered notable setbacks in ...